A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2004
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004	US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application
12/16/2004	US20040253250 Compositions and methods for regulating lymphocyte activation
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253233 genetic engineered chimeric and humanized antibodies obtained from murine monoclonal antibody P3 (MAb P3) and its antiidiotypic antibodies, used as antitumor agents
12/16/2004	US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis
12/16/2004	US20040253229 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants
12/16/2004	US20040253208 Interleukin-1 muteins useful as vaccine adjuvants
12/16/2004	US20040253205 c-Kit kinase inhibitor
12/16/2004	DE10323966A1 Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen New long-acting drug combinations for the treatment of respiratory disorders
12/16/2004	CA2531569A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stemcell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transformation introducing the gene
12/16/2004	CA2528727A1 Immunomodulating compositions, uses therefor and processes for their production
12/16/2004	CA2526694A1 Amidino compounds as cysteine protease inhibitors
12/16/2004	CA2526638A1 Method of mitigating the adverse effects of il-2
12/16/2004	CA2524910A1 Therapeutical composition containing dendritic cells and use thereof
12/15/2004	EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition
12/15/2004	EP1486507A1 Transmembrane nfat inhibitory peptide
12/15/2004	EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels
12/15/2004	EP1486494A1 N-substituted benzothiophenesulfonamide derivative
12/15/2004	EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
12/15/2004	EP1486213A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis
12/15/2004	EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
12/15/2004	EP1485719A2 Peptide epitopes common to antigens of the same multigene family
12/15/2004	EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants
12/15/2004	EP1485477A2 Novel type-1 cytokine receptor glm-r
12/15/2004	EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
12/15/2004	EP1485466A2 Methods for treating diseases or conditions with peptide constructs
12/15/2004	EP1485403A2 Compositions and methods to initiate or enhance antibody and major-histocompatibility class i or class ii-restricted t cell responses by using immunomodulatory, non-coding rna motifs
12/15/2004	EP1485396A2 Nucleoside 5'-monophosphate mimics and their prodrugs
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485377A1 Pyranones useful as atm inhibitors
12/15/2004	EP1485375A1 Pyrimidine compounds
12/15/2004	EP1485374A1 Pyrimidine compounds
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485360A2 Sodium channel blockers
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485347A2 Hif hydroxylase inhibitors
12/15/2004	EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
12/15/2004	EP1485130A2 Reagents and treatment methods for autoimmune diseases
12/15/2004	EP1485126A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
12/15/2004	EP1485125A1 Improvements in vaccination
12/15/2004	EP1485114A2 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
12/15/2004	EP1485109A1 Vascular therapeutics
12/15/2004	EP1485107A1 Phospholipids as caspase inhibitor prodrugs
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
12/15/2004	EP1485092A1 Use of rapamycin for inhibiting of cell death
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
12/15/2004	EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists
12/15/2004	EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/15/2004	EP1485075A2 Mhc-peptide complex binding ligands
12/15/2004	EP1485064A2 Method for production of phytoalexins
12/15/2004	EP1399155A4 Small molecules useful in the treatment of inflammatory disease
12/15/2004	EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
12/15/2004	EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists
12/15/2004	EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients
12/15/2004	EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004	EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/15/2004	EP1263779B1 Self antigen vaccines for treating b cell lymphomas and other cancers
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1207899B1 Treatment of allergic rhinitis with certain vasoactive amine binding proteins
12/15/2004	EP1073461B1 Viral chimeras comprised of caev and hiv-1 genetic elements
12/15/2004	EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004	EP1017283B1 Polynucleotide vaccine formulations
12/15/2004	EP1015025B1 T-cell vaccination for the treatment of multiple sclerosis
12/15/2004	EP0956304B1 Dendritic cell-specific antibodies
12/15/2004	EP0630252B1 Pharmaceutical preparation based on rhamnolipid against dermatological diseases
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives
12/15/2004	CN1555272A Compositions and methods for modulation of immune responses
12/15/2004	CN1555271A Interleukin-12 as a veterinary vaccine adjuvant
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier
12/15/2004	CN1554446A Carrier transferred adjuvant antigen and its preparing method
12/15/2004	CN1554443A Oral liquid for increasing hemogram, enhancing immunity and inhibiting tumour in cancer radiation and chemical therapy
12/15/2004	CN1554359A Process for preparing cytosine suanine dinuleotide sequence molecule immunopotentiator
12/15/2004	CN1554356A Method for preparing baicalin liquid
12/15/2004	CN1180079C Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
12/15/2004	CN1179971C Adjuvent DC-chol, its liposome, preparation method and its use
12/15/2004	CN1179970C Purine derivatives
12/15/2004	CN1179968C Scrophularia oligose, production method and use thereof
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179945C Indole derivatives, process for preparation of same and use thereof
12/15/2004	CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/15/2004	CN1179727C Epiderm specificity transfer factor
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831106 Vitamin D analogues
12/14/2004	US6831091 Anticancer agents
12/14/2004	US6831085 Methods and compositions utilizing quinazolinones
12/14/2004	US6831076 Epothilons C and D, preparation and compositions
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831069 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/14/2004	US6831067 Substance having physiological property, method for producing the same and uses thereof
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof

1 ... 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 ... 1172